Solitary Fibrous Tumor Treatment Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solitary Fibrous Tumor Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Surgery
1.2.3 Radiation Therapy
1.2.4 Adjuvant Chemotherapy
1.3 Market by Application
1.3.1 Global Solitary Fibrous Tumor Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Solitary Fibrous Tumor Treatment Market Perspective (2017-2028)
2.2 Solitary Fibrous Tumor Treatment Growth Trends by Region
2.2.1 Solitary Fibrous Tumor Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Solitary Fibrous Tumor Treatment Historic Market Size by Region (2017-2022)
2.2.3 Solitary Fibrous Tumor Treatment Forecasted Market Size by Region (2023-2028)
2.3 Solitary Fibrous Tumor Treatment Market Dynamics
2.3.1 Solitary Fibrous Tumor Treatment Industry Trends
2.3.2 Solitary Fibrous Tumor Treatment Market Drivers
2.3.3 Solitary Fibrous Tumor Treatment Market Challenges
2.3.4 Solitary Fibrous Tumor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solitary Fibrous Tumor Treatment Players by Revenue
3.1.1 Global Top Solitary Fibrous Tumor Treatment Players by Revenue (2017-2022)
3.1.2 Global Solitary Fibrous Tumor Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Solitary Fibrous Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Solitary Fibrous Tumor Treatment Revenue
3.4 Global Solitary Fibrous Tumor Treatment Market Concentration Ratio
3.4.1 Global Solitary Fibrous Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solitary Fibrous Tumor Treatment Revenue in 2021
3.5 Solitary Fibrous Tumor Treatment Key Players Head office and Area Served
3.6 Key Players Solitary Fibrous Tumor Treatment Product Solution and Service
3.7 Date of Enter into Solitary Fibrous Tumor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Solitary Fibrous Tumor Treatment Breakdown Data by Type
4.1 Global Solitary Fibrous Tumor Treatment Historic Market Size by Type (2017-2022)
4.2 Global Solitary Fibrous Tumor Treatment Forecasted Market Size by Type (2023-2028)
5 Solitary Fibrous Tumor Treatment Breakdown Data by Application
5.1 Global Solitary Fibrous Tumor Treatment Historic Market Size by Application (2017-2022)
5.2 Global Solitary Fibrous Tumor Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Solitary Fibrous Tumor Treatment Market Size (2017-2028)
6.2 North America Solitary Fibrous Tumor Treatment Market Size by Country (2017-2022)
6.3 North America Solitary Fibrous Tumor Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Solitary Fibrous Tumor Treatment Market Size (2017-2028)
7.2 Europe Solitary Fibrous Tumor Treatment Market Size by Country (2017-2022)
7.3 Europe Solitary Fibrous Tumor Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solitary Fibrous Tumor Treatment Market Size (2017-2028)
8.2 Asia-Pacific Solitary Fibrous Tumor Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Solitary Fibrous Tumor Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Solitary Fibrous Tumor Treatment Market Size (2017-2028)
9.2 Latin America Solitary Fibrous Tumor Treatment Market Size by Country (2017-2022)
9.3 Latin America Solitary Fibrous Tumor Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solitary Fibrous Tumor Treatment Market Size (2017-2028)
10.2 Middle East & Africa Solitary Fibrous Tumor Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Solitary Fibrous Tumor Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Detail
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Solitary Fibrous Tumor Treatment Introduction
11.1.4 Pfizer, Inc. Revenue in Solitary Fibrous Tumor Treatment Business (2017-2022)
11.1.5 Pfizer, Inc. Recent Development
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Detail
11.2.2 F. Hoffmann-La Roche Ltd. Business Overview
11.2.3 F. Hoffmann-La Roche Ltd. Solitary Fibrous Tumor Treatment Introduction
11.2.4 F. Hoffmann-La Roche Ltd. Revenue in Solitary Fibrous Tumor Treatment Business (2017-2022)
11.2.5 F. Hoffmann-La Roche Ltd. Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Detail
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Solitary Fibrous Tumor Treatment Introduction
11.3.4 Eli Lilly and Company Revenue in Solitary Fibrous Tumor Treatment Business (2017-2022)
11.3.5 Eli Lilly and Company Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Detail
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Solitary Fibrous Tumor Treatment Introduction
11.4.4 Bayer AG Revenue in Solitary Fibrous Tumor Treatment Business (2017-2022)
11.4.5 Bayer AG Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Detail
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Solitary Fibrous Tumor Treatment Introduction
11.5.4 Novartis AG Revenue in Solitary Fibrous Tumor Treatment Business (2017-2022)
11.5.5 Novartis AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Solitary Fibrous Tumor Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Surgery
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Adjuvant Chemotherapy
Table 5. Global Solitary Fibrous Tumor Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Solitary Fibrous Tumor Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Solitary Fibrous Tumor Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Solitary Fibrous Tumor Treatment Market Share by Region (2017-2022)
Table 9. Global Solitary Fibrous Tumor Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Solitary Fibrous Tumor Treatment Market Share by Region (2023-2028)
Table 11. Solitary Fibrous Tumor Treatment Market Trends
Table 12. Solitary Fibrous Tumor Treatment Market Drivers
Table 13. Solitary Fibrous Tumor Treatment Market Challenges
Table 14. Solitary Fibrous Tumor Treatment Market Restraints
Table 15. Global Solitary Fibrous Tumor Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Solitary Fibrous Tumor Treatment Market Share by Players (2017-2022)
Table 17. Global Top Solitary Fibrous Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solitary Fibrous Tumor Treatment as of 2021)
Table 18. Ranking of Global Top Solitary Fibrous Tumor Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Solitary Fibrous Tumor Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Solitary Fibrous Tumor Treatment Product Solution and Service
Table 22. Date of Enter into Solitary Fibrous Tumor Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Solitary Fibrous Tumor Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Solitary Fibrous Tumor Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Solitary Fibrous Tumor Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Solitary Fibrous Tumor Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Solitary Fibrous Tumor Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Solitary Fibrous Tumor Treatment Revenue Market Share by Application (2017-2022)
Table 30. Global Solitary Fibrous Tumor Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Solitary Fibrous Tumor Treatment Revenue Market Share by Application (2023-2028)
Table 32. North America Solitary Fibrous Tumor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Solitary Fibrous Tumor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Solitary Fibrous Tumor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Solitary Fibrous Tumor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Solitary Fibrous Tumor Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Solitary Fibrous Tumor Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Solitary Fibrous Tumor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Solitary Fibrous Tumor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Solitary Fibrous Tumor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Solitary Fibrous Tumor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 42. Pfizer, Inc. Company Detail
Table 43. Pfizer, Inc. Business Overview
Table 44. Pfizer, Inc. Solitary Fibrous Tumor Treatment Product
Table 45. Pfizer, Inc. Revenue in Solitary Fibrous Tumor Treatment Business (2017-2022) & (US$ Million)
Table 46. Pfizer, Inc. Recent Development
Table 47. F. Hoffmann-La Roche Ltd. Company Detail
Table 48. F. Hoffmann-La Roche Ltd. Business Overview
Table 49. F. Hoffmann-La Roche Ltd. Solitary Fibrous Tumor Treatment Product
Table 50. F. Hoffmann-La Roche Ltd. Revenue in Solitary Fibrous Tumor Treatment Business (2017-2022) & (US$ Million)
Table 51. F. Hoffmann-La Roche Ltd. Recent Development
Table 52. Eli Lilly and Company Company Detail
Table 53. Eli Lilly and Company Business Overview
Table 54. Eli Lilly and Company Solitary Fibrous Tumor Treatment Product
Table 55. Eli Lilly and Company Revenue in Solitary Fibrous Tumor Treatment Business (2017-2022) & (US$ Million)
Table 56. Eli Lilly and Company Recent Development
Table 57. Bayer AG Company Detail
Table 58. Bayer AG Business Overview
Table 59. Bayer AG Solitary Fibrous Tumor Treatment Product
Table 60. Bayer AG Revenue in Solitary Fibrous Tumor Treatment Business (2017-2022) & (US$ Million)
Table 61. Bayer AG Recent Development
Table 62. Novartis AG Company Detail
Table 63. Novartis AG Business Overview
Table 64. Novartis AG Solitary Fibrous Tumor Treatment Product
Table 65. Novartis AG Revenue in Solitary Fibrous Tumor Treatment Business (2017-2022) & (US$ Million)
Table 66. Novartis AG Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Solitary Fibrous Tumor Treatment Market Share by Type: 2021 VS 2028
Figure 2. Surgery Features
Figure 3. Radiation Therapy Features
Figure 4. Adjuvant Chemotherapy Features
Figure 5. Global Solitary Fibrous Tumor Treatment Market Share by Application in 2021 & 2028
Figure 6. Hospital Case Studies
Figure 7. Ambulatory Surgical Center Case Studies
Figure 8. Others Case Studies
Figure 9. Solitary Fibrous Tumor Treatment Report Years Considered
Figure 10. Global Solitary Fibrous Tumor Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Solitary Fibrous Tumor Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Solitary Fibrous Tumor Treatment Market Share by Region: 2021 VS 2028
Figure 13. Global Solitary Fibrous Tumor Treatment Market Share by Players in 2021
Figure 14. Global Top Solitary Fibrous Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solitary Fibrous Tumor Treatment as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Solitary Fibrous Tumor Treatment Revenue in 2021
Figure 16. North America Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Solitary Fibrous Tumor Treatment Market Share by Country (2017-2028)
Figure 18. United States Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Solitary Fibrous Tumor Treatment Market Share by Country (2017-2028)
Figure 22. Germany Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Solitary Fibrous Tumor Treatment Market Share by Region (2017-2028)
Figure 30. China Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Solitary Fibrous Tumor Treatment Market Share by Country (2017-2028)
Figure 38. Mexico Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Solitary Fibrous Tumor Treatment Market Share by Country (2017-2028)
Figure 42. Turkey Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Solitary Fibrous Tumor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Pfizer, Inc. Revenue Growth Rate in Solitary Fibrous Tumor Treatment Business (2017-2022)
Figure 45. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Solitary Fibrous Tumor Treatment Business (2017-2022)
Figure 46. Eli Lilly and Company Revenue Growth Rate in Solitary Fibrous Tumor Treatment Business (2017-2022)
Figure 47. Bayer AG Revenue Growth Rate in Solitary Fibrous Tumor Treatment Business (2017-2022)
Figure 48. Novartis AG Revenue Growth Rate in Solitary Fibrous Tumor Treatment Business (2017-2022)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Industry Market Size
